# US 2026/0242774 A1 · Single-stranded end preserving adaptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0242774 A1
- Document ID: US20260242774A1
- Status: Published application
- Kind: A1
- Application number: 19/662,739
- Filed: 2026-04-29
- Published: 2026-08-20
- Earliest claimed: 2024-02-22
- Assignees: Canal Biosciences, Inc.
- Applicants: Canal Biosciences, INC
- Inventors: Yu ZHENG
- Web page: https://patentgrep.com/patent/US20260242774A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/2497: {hydrolysing N- glycosyl compounds (3.2.2)}
- C12N 9/93: {Ligases (6)}
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6869: Methods for sequencing
- C12Y 207/01078: Polynucleotide 5'-hydroxyl-kinase (2.7.1.78)
- C12Y 605/01003: RNA ligase (ATP) (6.5.1.3)
- C12Q 2521/501: Ligase
- C12Q 2525/186: incorporating a non-extendable or blocking moiety
- C12Q 2525/191: incorporating an adaptor
- C12Q 2531/113: PCR
- C12Q 2535/122: Massive parallel sequencing
- C12Q 2563/179: the label being a nucleic acid
- C12Y 301/21007: Deoxyribonuclease V (3.1.21.7)
- C12Y 302/02027: Uracil-DNA glycosylase (3.2.2.27)
- C12Y 605/01: forming phosphoric ester bonds (6.5.1)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Provided herein are compositions, kits, systems, and methods employing single-stranded end-preserving adaptors. Such single-stranded adaptors are attached to DNA duplex molecules while preserving original 5′ or 3′ single-strand protruding ends (e.g., present in cell-free DNA) by attaching such adapters to 3′ ends the DNA duplex molecules using a single strand ligase that has step 3 ligase activity, but not step 2 adenylyl transfer activity, and attaching such adapters to the 5′ ends of the DNA duplex molecules using a ligase enzyme (e.g., a circligase), thereby forming loop-like structures on one or each end of the DNA duplex molecules. In further embodiments, the loop-like structures are cleaved (e.g., by an endonuclease) as the single-stranded adapters have a cleavable portion, thereby generating a two-part adapter on one or both ends of the DNA duplex molecules that preserves the initial 5′ or 3′ single-strand protruding ends, along with any methylation present.

## Claims

### Claim 1

A kit comprising:
a) a plurality of single-stranded adaptors, wherein each of said single-stranded adaptors comprises:
i) a nucleic acid sequence comprising a 5′ end and a 3′ end,
ii) a 3′ end blocking group attached to the said 3′ end of said nucleic acid sequence, and
iii) wherein said 5′ end of said nucleic acid sequence is adenylated, and
wherein said nucleic acid sequence further comprises: a 5′ region, a 3′ region, and a cleavable region between said 5′ and 3′ regions, wherein said cleavable region comprise a nucleic acid backbone linkage,
b) a single strand ligase, wherein said single strand ligase has step 3 ligase activity, but not step 2 adenylyl transfer activity,
c) an RtcB enzyme, and
d) a deblocking agent.

### Claim 2 (depends on 1)

The kit of claim 1, wherein said deblocking agent comprises an enzyme with phosphatase activity.

### Claim 3 (depends on 1)

The kit of claim 1, wherein said enzyme with phosphatase activity is selected from the group consisting of: T4 polynucleotide kinase, an alkaline phosphatase, calf intestinal alkaline phosphatase (CIP), and shrimp alkaline phosphatase (SAP).

### Claim 4 (depends on 1)

The kit of claim 1, wherein said single strand ligase is a thermostable lysine-mutant ssDNA/RNA ligase which is a mutated version of a precursor thermostable ssDNA/RNA ligase that has a Motif I EKx(D/N/H)G,
wherein said thermostable lysine-mutant replaces lysine (K) in said Motif I with an amino acid selected from alanine (A), serine (S), cysteine (C), valine (V), threonine (T), and Glycine (G), and
wherein replacement of said lysine (K) in said Motif I results in said thermostable lysine-mutant ssDNA/RNA ligase to have said step 3 ligase activity, but not said step 2 adenylyl transfer activity that is present in said precursor thermostable ssDNA/RNA ligase.

### Claim 5 (depends on 4)

The kit of claim 4, wherein said amino acid is said alanine (A).

### Claim 6 (depends on 1)

The kit of claim 1, wherein said single strand ligase has an amino acid sequence that is 95% or 100% identical to SEQ ID NOs:6.

### Claim 7 (depends on 1)

The kit of claim 1, wherein said 3′ region of said first nucleic acid sequence comprises a read 1 primer binding sequence, and wherein said 5′ region of said first nucleic acid sequence comprises a read 2 primer binding sequence.

### Claim 8 (depends on 1)

The kit of claim 1, wherein said 5′ and 3′ regions of said first nucleic acid sequence each comprise a barcode sequence that have a predefined relationship to each other, and wherein said barcode sequences are non-complementary to each other.

### Claim 9 (depends on 1)

The kit of claim 1, further comprising one or more containers for collectively or separately holding the recited components, optionally, wherein said components are present inside said container.

### Claim 10 (depends on 9)

The kit of claim 9, wherein said one or more containers is selected from a cardboard box, a plastic bag or box, glass vials, and plastic vials.

### Claim 11

A kit comprising:
a) a plurality of single-stranded adaptors, wherein each of said single-stranded adaptors comprises:
i) a nucleic acid sequence comprising a 5′ end and a 3′ end,
ii) a 3′ end blocking group attached to the said 3′ end of said nucleic acid sequence, and
iii) wherein said 5′ end of said nucleic acid sequence is adenylated, and
wherein said nucleic acid sequence further comprises: a 5′ region, a 3′ region, and a cleavable region between said 5′ and 3′ regions, wherein said cleavable region comprise a nucleic acid backbone linkage,
b) a single strand ligase, wherein said single strand ligase has step 3 ligase activity, but not step 2 adenylyl transfer activity,
c) an RtcB enzyme, and
d) an enzyme with phosphatase activity.

### Claim 12 (depends on 11)

The kit of claim 11, wherein said 3′ blocking group comprises a 3′ spacer.

### Claim 13 (depends on 11)

The kit of claim 11, wherein said 3′ blocking comprises a phosphate, a dideoxyC, or a biotin.

### Claim 14 (depends on 11)

The kit of claim 11, wherein said RtcB enzyme comprises a thermostable RtcB enzyme.

### Claim 15 (depends on 14)

The kit of claim 14, wherein said thermostable RtcB enzyme is from Thermus thermophilus.

### Claim 16 (depends on 11)

The kit of claim 11, wherein said single strand ligase is a thermostable lysine-mutant ssDNA/RNA ligase which is a mutated version of a precursor thermostable ssDNA/RNA ligase that has a Motif I EKx(D/N/H)G,
wherein said thermostable lysine-mutant replaces lysine (K) in said Motif I with an amino acid selected from alanine (A), serine (S), cysteine (C), valine (V), threonine (T), and Glycine (G), and
wherein replacement of said lysine (K) in said Motif I results in said thermostable lysine-mutant ssDNA/RNA ligase to have said step 3 ligase activity, but not said step 2 adenylyl transfer activity that is present in said precursor thermostable ssDNA/RNA ligase.

### Claim 17 (depends on 16)

The kit of claim 16, wherein said amino acid is said alanine (A).

### Claim 18 (depends on 11)

The kit of claim 11, wherein said 3′ region of said first nucleic acid sequence comprises a read 1 primer binding sequence, and wherein said 5′ region of said first nucleic acid sequence comprises a read 2 primer binding sequence.

### Claim 19 (depends on 11)

The kit of claim 11, wherein said 5′ and 3′ regions of said first nucleic acid sequence each comprise a barcode sequence that have a predefined relationship to each other, and wherein said barcode sequences are non-complementary to each other.

### Claim 20 (depends on 11)

The kit of claim 11, further comprising one or more containers for collectively or separately holding the recited components, optionally, wherein said components are present inside said container.
